These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 21427414)

  • 1. Role of tetrahydrobiopterin (BH4) in hyperhomocysteinemia-induced endothelial dysfuction: new indication for this orphan-drug?
    Kietadisorn R; Kietselaer BL; Schmidt HH; Moens AL
    Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1176; author reply E1177-8. PubMed ID: 21427414
    [No Abstract]   [Full Text] [Related]  

  • 2. Homocysteine impairs coronary artery endothelial function by inhibiting tetrahydrobiopterin in patients with hyperhomocysteinemia.
    He L; Zeng H; Li F; Feng J; Liu S; Liu J; Yu J; Mao J; Hong T; Chen AF; Wang X; Wang G
    Am J Physiol Endocrinol Metab; 2010 Dec; 299(6):E1061-5. PubMed ID: 20858749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrahydrobiopterin and endothelial nitric oxide synthase activity.
    Cosentino F; Lüscher TF
    Cardiovasc Res; 1999 Aug; 43(2):274-8. PubMed ID: 10536654
    [No Abstract]   [Full Text] [Related]  

  • 4. Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease.
    Channon KM
    Trends Cardiovasc Med; 2004 Nov; 14(8):323-7. PubMed ID: 15596110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible impact of tetrahydrobiopterin and sepiapterin on endothelial dysfunction.
    Blau N; Thöny B
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):913-4; author reply 914-5. PubMed ID: 12740227
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease.
    Schmidt TS; Alp NJ
    Clin Sci (Lond); 2007 Jul; 113(2):47-63. PubMed ID: 17555404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease.
    Alp NJ; Channon KM
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):413-20. PubMed ID: 14656731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells.
    Cai S; Khoo J; Channon KM
    Cardiovasc Res; 2005 Mar; 65(4):823-31. PubMed ID: 15721862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum homocysteine and endothelial dysfunction in circulatory disorders in women.
    Tsuda K; Nishio I
    Circulation; 2004 Jul; 110(4):e37. PubMed ID: 15277339
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of tetrahydrobiopterin on coronary vascular reactivity in atherosclerotic human coronary arteries.
    Worthley MI; Kanani RS; Sun YH; Sun Y; Goodhart DM; Curtis MJ; Anderson TJ
    Cardiovasc Res; 2007 Dec; 76(3):539-46. PubMed ID: 17689509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial ischemia results in tetrahydrobiopterin (BH4) oxidation with impaired endothelial function ameliorated by BH4.
    Dumitrescu C; Biondi R; Xia Y; Cardounel AJ; Druhan LJ; Ambrosio G; Zweier JL
    Proc Natl Acad Sci U S A; 2007 Sep; 104(38):15081-6. PubMed ID: 17848522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired endothelial function may be due to decreased aortic tetrahydrobiopterin, assessed by a new flow-mediated vasodilation in vivo in hypercholesterolemic/atherogenic mice.
    Tamura Y; Naemura A; Inoue A; Ijiri Y; Seki J; Yada T; Goto M; Shinohara M; Kawashima S; Giddings JC; Yamamoto J
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):699-705. PubMed ID: 19741507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular protection by tetrahydrobiopterin: progress and therapeutic prospects.
    Katusic ZS; d'Uscio LV; Nath KA
    Trends Pharmacol Sci; 2009 Jan; 30(1):48-54. PubMed ID: 19042039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
    Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrahydrobiopterin and endothelial function.
    Cosentino F; Lüscher TF
    Eur Heart J; 1998 Jul; 19 Suppl G():G3-8. PubMed ID: 9717048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pivotal role for endothelial tetrahydrobiopterin in pulmonary hypertension.
    Khoo JP; Zhao L; Alp NJ; Bendall JK; Nicoli T; Rockett K; Wilkins MR; Channon KM
    Circulation; 2005 Apr; 111(16):2126-33. PubMed ID: 15824200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic tetrahydrobiopterin (BH4) levels and coronary artery disease.
    Walter R; Blau N; Kierat L; Schoedon G; Reinhart WH
    Cardiology; 2000; 94(4):265-6. PubMed ID: 11326151
    [No Abstract]   [Full Text] [Related]  

  • 18. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension.
    Landmesser U; Dikalov S; Price SR; McCann L; Fukai T; Holland SM; Mitch WE; Harrison DG
    J Clin Invest; 2003 Apr; 111(8):1201-9. PubMed ID: 12697739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced vascular tetrahydrobiopterin (BH4) and endothelial function with ageing: is it time for a chronic BH4 supplementation trial in middle-aged and older adults?
    Pierce GL; Larocca TJ
    J Physiol; 2008 Jun; 586(11):2673-4. PubMed ID: 18388135
    [No Abstract]   [Full Text] [Related]  

  • 20. Gene transfer of human guanosine 5'-triphosphate cyclohydrolase I restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension.
    Zheng JS; Yang XQ; Lookingland KJ; Fink GD; Hesslinger C; Kapatos G; Kovesdi I; Chen AF
    Circulation; 2003 Sep; 108(10):1238-45. PubMed ID: 12925450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.